ClinicalTrialsFinder

HLA-A*0201 Positive Cells Present Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

HLA-A*0201 Positive Cells PresentClear Cell Sarcoma (CCS)
Sarcoma Alliance for Research through Collaboration47 enrolled2 locationsNCT06942442